0001209191-21-009112.txt : 20210209
0001209191-21-009112.hdr.sgml : 20210209
20210209211253
ACCESSION NUMBER: 0001209191-21-009112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210206
FILED AS OF DATE: 20210209
DATE AS OF CHANGE: 20210209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shukla Sanjay
CENTRAL INDEX KEY: 0001671026
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 21608849
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-06
0
0001339970
aTYR PHARMA INC
LIFE
0001671026
Shukla Sanjay
3545 JOHN HOPKINS COURT, SUITE #250
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
Common stock
2021-02-06
4
M
0
1785
A
9076
D
Common stock
2021-02-09
4
S
0
778
7.66
D
8298
D
Restricted Stock Unit
2021-02-06
4
M
0
1785
0.00
D
Common Stock
1785
0
D
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 6, 2019.
Restricted stock units convert into common stock on a one-for-one basis.
Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 6, 2019.
The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020.
Nancy E. Denyes, attorney-in-fact
2021-02-09